Synthesis and Application of a Near-Infrared Light-Emitting Fluorescent Probe for Specific Imaging of Cancer Cells with High Sensitivity and Selectivity

References

• Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33. doi:10.3322/caac.21708
   PubMed Web of Science ®Google Scholar
• Tyson DM, Chavez MN, Lake P, et al. Perceptions of prescription opioid medication within the context of cancer survivorship and the opioid epidemic. J Cancer Surviv. 2021;15(4):585–596. doi:10.1007/s11764-020-00952-1
   PubMed Web of Science ®Google Scholar
• Schiffman JD, Fisher PG, Gibbs P. Early detection of cancer: past, present, and future. Am Soc Clin Oncol Educ Book. 2015;57–65. doi:10.14694/EdBook_AM.2015.35.57
   PubMedGoogle Scholar
• Zhang Y, Wang J. Targeting uptake transporters for cancer imaging and treatment. Acta Pharm Sin B. 2020;10(1):79–90. doi:10.1016/j.apsb.2019.12.005
   PubMed Web of Science ®Google Scholar
• Pierce MC, Javier DJ, Richards-Kortum R. Optical contrast agents and imaging systems for detection and diagnosis of cancer. Int, J, Cancer. 2008;123(9):1979–1990. doi:10.1002/ijc.23858
   PubMed Web of Science ®Google Scholar
• Zhu N, Guo X, Pang S, et al. Mitochondria-immobilized unimolecular fluorescent probe for multiplexing imaging of living cancer cells. Anal Chem. 2020;92(16):11103–11110. doi:10.1021/acs.analchem.0c01046
   PubMed Web of Science ®Google Scholar
• Cui C, Chakraborty K, Tang XA, et al. A lysosome-targeted DNA nanodevice selectively targets macrophages to attenuate tumours. Nat Nanotechnol. 2021;16(12):1394–1402. doi:10.1038/s41565-021-00988-z
   PubMed Web of Science ®Google Scholar
• X-y H, J-j L, Yang Z-W, Zhang J, Wang H-S. Fluorescent intracellular imaging of reactive oxygen species and pH levels moderated by a hydrogenase mimic in living cells. J Pharm Anal. 2022;12(5):801–807. doi:10.1016/j.jpha.2022.05.007
   PubMed Web of Science ®Google Scholar
• Li T, Yang J, Ali Z, et al. Synthesis of aptamer-functionalized Ag nanoclusters for MCF-7 breast cancer cells imaging. Sci China Chem. 2017;60:370–376. doi:10.1007/s11426-016-0159-2
   Web of Science ®Google Scholar
• Demir B, Lemberger MM, Panagiotopoulou M, et al. Tracking hyaluronan: molecularly imprinted polymer coated carbon dots for cancer cell targeting and imaging. ACS Appl Mater Interfaces. 2018;10(4):3305–3313. doi:10.1021/acsami.7b16225
   PubMed Web of Science ®Google Scholar
• Baghban R, Afarid M, Soleymani J, et al. Were magnetic materials useful in cancer therapy? Biomed Pharmacother. 2021;144:112321. doi:10.1016/j.biopha.2021.112321
   PubMed Web of Science ®Google Scholar
• Joshy KS, Augustine R, Mayeen A, et al. NiFe 2 O 4/poly (ethylene glycol)/lipid–polymer hybrid nanoparticles for anti-cancer drug delivery. New J Chem. 2020;44(42):18162–18172. doi:10.1039/d0nj01163k
   Web of Science ®Google Scholar
• Siddique S, Chow JCL. Application of nanomaterials in biomedical imaging and cancer therapy. Nanomaterials. 2020;10(9):1700. doi:10.3390/nano10091700
   Web of Science ®Google Scholar
• Gao Q, Zhang J, Gao J, et al. Gold Nanoparticles in Cancer Theranostics. Front Bioeng Biotechnol. 2021;9:647905. doi:10.3389/fbioe.2021.647905
   PubMed Web of Science ®Google Scholar
• Woo Y, Chaurasiya S, O’Leary M, et al. Fluorescent imaging for cancer therapy and cancer gene therapy. Mol Ther Oncolytics. 2021;23:231–238. doi:10.1016/j.omto.2021.06.007
   PubMed Web of Science ®Google Scholar
• Lamberts LE, Koch M, de Jong JS, et al. Tumor-specific uptake of fluorescent bevacizumab-IRDye800CW microdosing in patients with primary breast cancer: a Phase I Feasibility Study. Clin Cancer Res. 2017;23(11):2730–2741. doi:10.1158/1078-0432.CCR-16-0437
   PubMed Web of Science ®Google Scholar
• Nozaki S, Nakatani Y, Mawatari A, et al. 18F-FIMP: a LAT1-specific PET probe for discrimination between tumor tissue and inflammation. Sci Rep. 2019;9(1):15718. doi:10.1038/s41598-019-52270-x
   PubMedGoogle Scholar
• Jiao J, Zhang J, Yang F, et al. Quicker, deeper and stronger imaging: a review of tumor-targeted, near-infrared fluorescent dyes for fluorescence guided surgery in the preclinical and clinical stages. Eur J Pharm Biopharm. 2020;152:123–143. doi:10.1016/j.ejpb.2020.05.002
   PubMed Web of Science ®Google Scholar
• Zhu S, Tian R, Antaris AL, et al. Near-infrared-II molecular dyes for cancer imaging and surgery. Adv Mater. 2019;31(24):e1900321. doi:10.1002/adma.201900321
   PubMed Web of Science ®Google Scholar
• Zhang E, Luo S, Tan X, et al. Mechanistic study of IR-780 dye as a potential tumor targeting and drug delivery agent. Biomaterials. 2014;35(2):771–778. doi:10.1016/j.biomaterials.2013.10.033
   PubMed Web of Science ®Google Scholar
• Luo S, Zhang E, Su Y, et al. A review of NIR dyes in cancer targeting and imaging. Biomaterials. 2011;32(29):7127–7138. doi:10.1016/j.biomaterials.2011.06.024
   PubMed Web of Science ®Google Scholar
• Das RS, Mukherjee A, Kar S, et al. Construction of red fluorescent dual targeting mechanically interlocked molecules for live cancer cell specific lysosomal staining and multicolor cellular imaging. Org Lett. 2022;24(32):5907–5912. doi:10.1021/acs.orglett.2c02114
   PubMed Web of Science ®Google Scholar
• Wang W, Ma Z, Zhu S, et al. Molecular cancer imaging in the second near-infrared window using a renal-excreted NIR-II fluorophore-peptide probe. Adv Mater. 2018;30(22):e1800106. doi:10.1002/adma.201800106
   PubMed Web of Science ®Google Scholar
• Xing Q, Wang X, Yan X, et al. Multifunctional butterfly-shaped cyanine dyes: aggregation-induced emission, high-contrast mechanochromic luminescence, mitochondrial-specific staining and tumor imaging. Dyes Pigm. 2021;88:109232. doi:10.1016/j.dyepig.2021.109232
   Google Scholar
• Kanai Y. Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics. Pharmacol Ther. 2022;230:107964. doi:10.1016/j.pharmthera.2021.107964
   PubMed Web of Science ®Google Scholar
• Holley RW. A unifying hypothesis concerning the nature of malignant growth. Proc Natl Acad Sci U S A. 1972;69(10):2840–2841. doi:10.1073/pnas.69.10.2840
   PubMed Web of Science ®Google Scholar
• Yan R, Zhao X, Lei J, Zhou Q. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex. Nature. 2019;568(7750):127–130. doi:10.1038/s41586-019-1011-z
   PubMed Web of Science ®Google Scholar
• Scalise M, Galluccio M, Console L, Pochini L, Indiveri C. The human SLC7A5 (LAT1): the intriguing histidine/large neutral amino acid transporter and its relevance to human health. Front Chem. 2018;6:243. doi:10.3389/fchem.2018.00243
   PubMed Web of Science ®Google Scholar
• Bhutia YD, Babu E, Ramachandran S, Ganapathy V. Amino acid transporters in cancer and their relevance to “Glutamine Addiction”: novel targets for the design of a new class of anticancer drugs. Cancer Res. 2015;75(9):1782–1788. doi:10.1158/0008-5472.Can-14-3745
   PubMed Web of Science ®Google Scholar
• Okano N, Naruge D, Kawai K, et al. First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumors. Invest New Drugs. 2020;38(5):1495–1506. doi:10.1007/s10637-020-00924-3
   PubMed Web of Science ®Google Scholar
• Häfliger P, Charles RP. The L-type amino acid transporter LAT1-an emerging target in cancer. Int J Mol Sci. 2019;20(10):2428. doi:10.3390/ijms20102428
   PubMed Web of Science ®Google Scholar
• Shindo H, Harada-Shoji N, Ebata A, et al. Targeting amino acid metabolic reprogramming via L-type amino acid transporter 1 (LAT1) for endocrine-resistant breast cancer. Cancers. 2021;13(17):4375. doi:10.3390/cancers13174375
   PubMed Web of Science ®Google Scholar
• Fuchs BC, Bode BP. Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? Semin Cancer Biol. 2005;15(4):254–266. doi:10.1016/j.semcancer.2005.04.005
   PubMed Web of Science ®Google Scholar
• Das RS, Maiti D, Kar S, et al. Design of Water–soluble rotaxane-capped superparamagnetic, ultrasmall Fe3O4 nanoparticles for targeted NIR fluorescence imaging in combination with magnetic resonance imaging. J Am Chem Soc. 2023;145(37):20451–20461. doi:10.1021/jacs.3c06232
   PubMed Web of Science ®Google Scholar
• David CI, Prabakaran G, Sundaram K, et al. Rhodanine-based fluorometric sequential monitoring of silver (I) and iodide ions: experiment, DFT calculation and multifarious applications. J Hazard Mater. 2021:419. doi:10.1016/j.jhazmat.2021.126449
   Web of Science ®Google Scholar
• Zheng J, Zhou C, Yu M, et al. Different sized luminescent gold nanoparticles. Nanoscale. 2012;4(14):4073–4083. doi:10.1039/c2nr31192e
   PubMed Web of Science ®Google Scholar
• Deng HH, Zhang LN, He SB, et al. Methionine-directed fabrication of gold nanoclusters with yellow fluorescent emission for Cu(2+) sensing. Biosens Bioelectron. 2015;65:397–403. doi:10.1016/j.bios.2014.10.071
   PubMed Web of Science ®Google Scholar
• Maruyama T, Fujimoto Y, Maekawa T. Synthesis of gold nanoparticles using various amino acids. J Colloid Interface Sci. 2015;447:254–257. doi:10.1016/j.jcis.2014.12.046
   PubMed Web of Science ®Google Scholar
• Peng Y, Wang M, Wu X, et al. Methionine-capped gold nanoclusters as a fluorescence-enhanced probe for Cadmium(II) sensing. Sensors. 2018;18(2):658. doi:10.3390/s18020658
   PubMed Web of Science ®Google Scholar
• Sang F, Zhang X, Shen F. Fluorescent methionine-capped gold nanoclusters for ultra-sensitive determination of copper(II) and cobalt(II), and their use in a test strip. Mikrochim Acta. 2019;186(6):373. doi:10.1007/s00604-019-3428-3
   PubMed Web of Science ®Google Scholar
• Bian RX, Wu XT, Chai F, et al. Facile preparation of fluorescent Au nanoclusters-based test papers for recyclable detection of Hg2+ and Pb2+. Sens Actuators B Chem. 2017;241:592–600. doi:10.1016/j.snb.2016.10.120
   Web of Science ®Google Scholar
• Zheng Y, Wu J, Jiang H, et al. Gold nanoclusters for theranostic applications. Coord Chem R. 2021;431:213689. doi:10.1016/j.ccr.2020.213689
   Web of Science ®Google Scholar
• Li L, Di X, Wu M, et al. Targeting tumor highly-expressed LAT1 transporter with amino acid-modified nanoparticles: toward a novel active targeting strategy in breast cancer therapy. Nanomedicine. 2017;13(3):987–998. doi:10.1016/j.nano.2016.11.012
   PubMed Web of Science ®Google Scholar
• Purohit R, Singh S. Fluorescent gold nanoclusters for efficient cancer cell targeting. Int J Nanomed. 2018;13(T–NANO 2014 Abstracts):15–17. doi:10.2147/IJN.S125003
   PubMedGoogle Scholar